{"id":"NCT00343460","sponsor":"Heron Therapeutics","briefTitle":"APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer","officialTitle":"A Pivotal Phase 3 Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi For The Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea and Vomiting Following The Administration of Either Moderately or Highly Emetogenic Chemotherapy Regimens","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2008-09","completion":"2009-02","firstPosted":"2006-06-23","resultsPosted":"2016-12-28","lastUpdate":"2017-02-23"},"enrollment":1428,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Nausea and Vomiting","Unspecified Adult Solid Tumor, Protocol Specific"],"interventions":[{"type":"DRUG","name":"APF530","otherNames":[]},{"type":"DRUG","name":"dexamethasone","otherNames":[]},{"type":"DRUG","name":"Palonosetron Hydrochloride","otherNames":[]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Arm I","type":"ACTIVE_COMPARATOR"},{"label":"Arm II","type":"EXPERIMENTAL"},{"label":"Arm III","type":"EXPERIMENTAL"}],"summary":"This randomized phase III trial is studying APF530 and dexamethasone to see how well they work compared with palonosetron and dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for cancer.","primaryOutcome":{"measure":"Proportion of Patients With Complete Response (CR) During Acute Phase (0-24 Hours) After Administration of Chemotherapy Course 1","timeFrame":"0-24 Hours","effectByArm":[{"arm":"Cycle 1 APF530 5 mg - Moderately","deltaMin":160,"sd":null},{"arm":"Cycle 1 APF530 10 mg - Moderately","deltaMin":163,"sd":null},{"arm":"Cycle 1 Aloxi 0.25 mg - Moderately","deltaMin":156,"sd":null},{"arm":"Cycle 1 APF530 5 mg - Highly","deltaMin":178,"sd":null},{"arm":"Cycle 1 APF530 10 mg - Highly","deltaMin":195,"sd":null},{"arm":"Cycle 1 Aloxi 0.25 Highly","deltaMin":192,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":52,"countries":["United States"]},"refs":{"pmids":["26921245","26289588"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":464},"commonTop":["Injection site bruising","Constipation","Fatigue","Anaemia","Nausea"]}}